Arix Bioscience, a healthcare and life science company, today announces planned changes to its executive team to prepare for its next phase of growth and development. Dr Joe Anderson, who has served as Chief Executive Officer of Arix since its inception in 2016, will transition to Chief Investment Officer. He will continue to Chair the Investment Committee and as of today, September 4 2018, will step down from the Board of Arix. Executive Chairman of Arix, Jonathan Peacock, will assume corporate and operating responsibilities and, working closely with the Board of Arix, will lead the process of recruiting a Chief Executive Officer.

EuropaBio today confirmed the appointment of Joanna Dupont-Inglis as its new Secretary General.
Commenting on this promotion, EuropaBio chair, Tjerk de Ruiter, said “Joanna has an excellent track record of leadership and engagement in this sector. Her experience will be valuable in working together with an increasingly broad community of stakeholders to ensure that the benefits of biotech can be accessed in Europe’’.